A survey describing the use of complementary therapies and medicines by women attending a family planning clinic

BMC Complementary and Alternative Medicine

Edith Weisberg²  Deborah J Bateson²  Caroline A Smith¹ 

[1]Centre for Complementary Medicine Research, University of Western Sydney, Penrith, Australia

[2]Family Planning New South Wales, Sydney, Australia

关键词: Survey;    Family planning;    Reproductive health;    Women’s health;    Complementary therapies and medicines;   

Others  :  1220996
DOI  :  10.1186/1472-6882-13-224

 received in 2013-02-20, accepted in 2013-09-02,  发布年份 2013

【 摘 要 】

Background

Complementary medicines (CMs) are widely used by women. Although, women in Australia are frequent users of CM, few studies have examined their utilisation by women attending a family planning service. The aim of this study was to examine (i) the extent of and type of CM, (ii) women’s views about safety and efficacy, and (iii) the factors influencing women’s decision-making.

Methods

A cross-sectional survey using a convenience sample of 221women aged greater than 18 years attending a family planning (FP) service was undertaken over a two week period in Sydney, Australia. An anonymous self-administered questionnaire was designed to examine women’s current and previous use of CMs, their attitudes towards safety and effectiveness, the factors influencing their decision-making, and their disclosure of CM use to a FP health professional. Demographic questions were designed to describe the diversity of the participants. Logistic regression was used to examine the association between CM use and demographics.

Results

Sixty-seven percent of women surveyed were currently using CMs, and 83% reported use during the previous 12 months. Most respondents utilised CMs to maintain their general health or for prevention of ill health. Over 30% of women lacked information to make an informed response to questions examining their views about the safety of CMs. Forty-four percent of participants stated they discussed their use of CMs with their FP providers. The main reason why women did not mention CMs was they did not see the relevance to their consultation (43%). Lower rates of CM use were found for younger women (OR 0.24, 95% CI 0.09-0.61), and those not completing high school (OR 0.44, 95% 0.20-1.00).

Conclusion

The use of CM is very common among women attending an Australian FP clinic, however our findings may not be generalisable to all women. We identified a notable gap in women’s awareness of the potential for interactions between CM and prescribed medication. Our findings also emphasise the need for healthcare providers to initiate discussions with clients about their utilisation of CM.

【 授权许可】

   
2013 Smith et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Lunny CA, Fraser SN: The use of complementary and alternative medicines among a sample of Canadian menopausal-aged women. J Midwifery Womens Health 2010, 55:335-343.
• [2]Rayner JA, Willis K, Burgess R: Women’s use of complementary and laternative medicine for fertility enhancement: a review of the literature. J Altern Complement Med 2011, 17(8):685-690.
• [3]Adams J, Sibbritt D, Lui CW: The use of complementary and alternative medicine during pregnancy: a longitudinal study of Australian women. Birth 2011, 38:200-206.
• [4]Yu SM, Ghandour RM, Huang ZJ: Herbal supplement use among US women. J Am Med Womens Assoc 2004, 59:17-24.
• [5]Gaffney L, Smith CA: The views of pregnant women towards the use of complementary therapies and medicines. Birth Issues 2004, 13:43-50.
• [6]Nordeng H, Havnen GC: Use of herbal drugs in pregnancy: a survey among 400 Norwegian women. Pharmacoepidemiol Drug Saf 2004, 13:371-380.
• [7]Lapi F, Vannacci A, Moschini M, et al.: Use, attitudes and knowledge of complementary and alternative drugs (CADs) among pregnant women: a preliminary survey in Tuscany. Evid Based Complement Alternat Med 2010, 7:477-486.
• [8]Holst L, Nordeng H, Haavik S: Use of herbal drugs during early pregnancy in relation to maternal characteristics and pregnancy outcome. Pharmacoepidemiol Drug Saf 2008, 17:151-159.
• [9]Wolsko PM, Eisenberg DM, Davis RB, Ettner SL, Phillips RS: Insurance coverage, medical conditions, and visits to alternative medicine providers: results of a national survey. Arch Intern Med 2002, 162(3):281-287.
• [10]Williamson M, Tudball J, Toms M, Garden F, Grunseit A: Information use and needs of complementary medicines users. Sydney: National Prescribing Service; 2008.
• [11]Eisenberg DM, Davis RB, Ettner SL, et al.: Trends in unconventional medicine use in the United States 1990–1997. JAMA 1998, 280:1569-1575.
• [12]Schwarz UI, Buschel B, Kirch W: Unwanted pregnancy on self medication with St John’s wort despite hormonmal contraception. Br J Clin Pharmacol 2003, 55:112-113.
• [13]Hall SD, Wanf Z, Shiew-Mei H, et al.: The interaction between St John’s wort and an oral contraceptive. Clin Pharmacol Ther 2003, 74:525-535.
• [14]Pfunder A, Schiesser M, Gerber S, et al.: Interaction of St John’s wort with low dose oral contraceptive therapy: a randomised controlled trial. Br J Clin Pharmacol 2003, 56:683-690.
• [15]Murphy PA, Kern SE, Stanczyk FZ, WEsthoff CL: Interaction of St John’s wort with oral contraceptive: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Contraception 2005, 71:402-408.
• [16]Royal College of Obstetricians and Gynaecologists: Drug interaction with hormonal contraception. London: Faculty of Sexual and Reproductive Healthcare. Clinical Effectiveness Unit; 2012.
• [17]Therapeutic Goods Administration: An overview of the regulation of complementary medicines in Australia. 2013. http://www.tga.gov.au/industry/cm-basics-regulation-overview.htm webcite
• [18]Robinson A, Cooper S: Trusted information sources: the preferred option for complementary and alternative medicine users. Complement Health Pract Rev 2007, 12:120.
• [19]Stankiewicz M, Smith C, Alvino H, Norman R: The use of complementary medicine and therapies by patients attending a reproductive medicine unit in South Australia: a prospective survey. Aust New Zeal J Obstet Gynaecol 2007, 47(2):145-149.
• [20]Xue C, Zhang A, Lin V, Da Costa C, Story D: Complementary and alternative medicine use in Australia: a national population based survey. J Altern Complement Med 2007, 13:643-650.
• [21]Harrigan JT: Patient disclosure of the use of complementary and alternative medicine to their obstetrician/gynaecologist. J Obstet Gynaecol 2011, 31(1):59-61.
• [22]Wieland LS, Manhiemer E, Berman BM: Development and classification of an operational definition oif complementary and alternative medicine for the Cochrane collaboration. Altern Ther Health Med 2011, 17(2):50-59.
• [23]World Health Organisation: Traditional medicine strategy 2002–2005. Geneva: World Health Organisation; 2002.